BBP · ARCA · ETF
Virtus Biotech ETF (BBP) Price, Holdings & Fees
Virtus Biotech ETF (BBP) closed at $715.43 on Oct 9, 2026, up 0.14% from the previous close of $714.41.
Share price, past year
1Y +25.84%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $715.43 |
| Sep 30, 2026 | $693.38 |
| Aug 31, 2026 | $669.50 |
| Jul 31, 2026 | $654.44 |
| Jun 30, 2026 | $660.62 |
| May 29, 2026 | $694.86 |
| Apr 30, 2026 | $728.27 |
| Mar 31, 2026 | $738.75 |
| Feb 27, 2026 | $676.71 |
| Jan 30, 2026 | $654.02 |
| Dec 31, 2025 | $613.34 |
| Nov 28, 2025 | $589.46 |
| Oct 31, 2025 | $570.90 |
Key statistics
- Expense ratio
- 0.34%
- as of Feb 28, 2026
- Net assets
- $98.5M
- as of Jul 31, 2026
- Holdings
- 70
- as of Jul 31, 2026
- 52-week range
- $556.37 – $741.23
Virtus Biotech ETF's expense ratio is 0.34%: $34.00 a year on $10,000 invested.
Holdings
Virtus Biotech ETF held 70 investments worth $98.54M as of Jul 31, 2026. Its largest holding was CRINETICS PHARMACEUTICALS INC, at 3.34% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | CRINETICS PHARMACEUTICALS INC | 3.34% | $3.29M |
| 2 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLCKNSA | 1.97% | $1.94M |
| 3 | VERASTEM INCVSTM | 1.95% | $1.92M |
| 4 | PRECIGEN INCPGEN | 1.94% | $1.91M |
| 5 | OMEROS CORPOMER | 1.87% | $1.84M |
| 6 | NUVATION BIO INCNUVB | 1.77% | $1.75M |
| 7 | REGENERON PHARMACEUTICALSREGN | 1.72% | $1.69M |
| 8 | PROTAGONIST THERAPEUTICS INCPTGX | 1.71% | $1.69M |
| 9 | ACADIA PHARMACEUTICALS INCACAD | 1.69% | $1.66M |
| 10 | BRIDGEBIO PHARMA INCBBIO | 1.65% | $1.63M |
| 11 | BEONE MEDICINES LTDONC | 1.65% | $1.62M |
| 12 | XERIS BIOPHARMA HOLDINGS INCXERS | 1.64% | $1.61M |
| 13 | HALOZYME THERAPEUTICS INCHALO | 1.64% | $1.61M |
| 14 | LIQUIDIA CORPLQDA | 1.63% | $1.60M |
| 15 | IMMUNOCORE HOLDINGS PLCIMCR | 1.61% | $1.58M |
| 16 | IRONWOOD PHARMACEUTICALS INCIRWD | 1.60% | $1.57M |
| 17 | ARROWHEAD PHARMACEUTICALS INCARWR | 1.56% | $1.54M |
| 18 | ROIVANT SCIENCES LTDROIV | 1.55% | $1.53M |
| 19 | LIGAND PHARMACEUTICALSLGND | 1.55% | $1.53M |
| 20 | RHYTHM PHARMACEUTICALS INCRYTM | 1.55% | $1.52M |
| 21 | GERON CORPGERN | 1.54% | $1.52M |
| 22 | RIGEL PHARMACEUTICALS INCRIGL | 1.54% | $1.52M |
| 23 | ASCENDIS PHARMA A/SASND | 1.54% | $1.52M |
| 24 | ARCUTIS BIOTHERAPEUTICS INCARQT | 1.52% | $1.50M |
| 25 | INCYTE CORPINCY | 1.52% | $1.49M |
Top 25 of 70 holdings, as of Jul 31, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 99.80% |
| Cash and short-term investments | 0.71% |
| Country | % of fund |
|---|---|
| United States | 84.60% |
| Cayman Islands | 3.58% |
| United Kingdom | 3.58% |
| Switzerland | 2.97% |
| Bermuda | 1.55% |
| Denmark | 1.54% |
| Germany | 1.38% |
| Canada | 1.30% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jul 31, 2026, Virtus Biotech ETF's total return was +10.81%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jul 31, 2026 | −2.67% |
| Jun 30, 2026 | +11.38% |
| May 31, 2026 | +2.22% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- Virtus Biotech ETF
- Ticker
- BBP
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- ETFis Series Trust I
- SEC series ID
- S000047354
- SEC CIK
- 0001559109
- Fractional shares
- Yes
Recent SEC filings
- Sep 29, 2026
- Oct 7, 2026
- 485BPOSProspectus updateJul 9, 2026
- Jul 2, 2026
- Apr 8, 2026
- 485BPOSProspectus updateFeb 27, 2026
- Jan 8, 2026
- 485BPOSProspectus updateNov 25, 2025
Shareholder reports and prospectuses are filed by ETFis Series Trust I, the trust behind Virtus Biotech ETF, and cover all of its funds.
Frequently asked questions
What is BBP's price?
Virtus Biotech ETF (BBP) closed at $715.43 on Oct 9, 2026, up 0.14% from the previous close of $714.41.
What is BBP's expense ratio?
Virtus Biotech ETF's expense ratio is 0.34%: $34.00 a year on $10,000 invested.
What does BBP hold?
Virtus Biotech ETF held 70 investments worth $98.54M as of Jul 31, 2026. Its largest holding was CRINETICS PHARMACEUTICALS INC, at 3.34% of the fund. Its five largest holdings were CRINETICS PHARMACEUTICALS INC, KINIKSA PHARMACEUTICALS INTERNATIONAL PLC, VERASTEM INC, PRECIGEN INC, OMEROS CORP.
How has BBP performed?
Over the 3 months to Jul 31, 2026, Virtus Biotech ETF's total return was +10.81%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jul 31, 2026 (filed Sep 29, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Feb 28, 2026. Prices are generated sample data for development. Data sources and disclosures